Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Receives CE Mark Under IVDR Certification for Digital Pathology Platform

Proscia
By Author Proscia | June 8, 2022

Digital pathology firm Proscia announced on Wednesday that its Concentriq Dx platform has received CE mark under Europe’s new In Vitro Diagnostic Regulation (IVDR) rules.

Our website uses cookies. By using this site, you agree to its use of cookies.